Back to Journals » OncoTargets and Therapy » Volume 10
Review
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,655 | Dovepress* | 12,652+ | 1,308 | 13,960 | |
PubMed Central* | 2,003 | 809 | 2,812 | ||
Totals | 14,655 | 2,117 | 16,772 | ||
*Since 10 July 2017 |
View citations on PubMed Central and Google Scholar